EICHOR
● Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis · Sponsor: Eli Lilly and Company
About this study
This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (261)
| Arizona Arthritis & Rheumatology Research, PLLC | Flagstaff, Arizona, United States | — |
| Arthrocare, Arthritiscare & Research PC | Gilbert, Arizona, United States | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Glendale, Arizona, United States | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Mesa, Arizona, United States | — |
| Hope Research Institute | Peoria, Arizona, United States | — |
| Hope Research Institute | Phoenix, Arizona, United States | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Tucson, Arizona, United States | — |
| Medvin Clinical Research - Covina | Covina, California, United States | — |
| St Joseph Heritage Healthcare | Fullerton, California, United States | — |
| Christine Thai, MD | Huntington Beach, California, United States | — |
| Private Practice - Dr. Christine J. Leehealey | Irvine, California, United States | — |
| Desert Medical Advances | Rancho Mirage, California, United States | — |
+ 249 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03915964